SCHEMBL1336348

SCHEMBL1336348

N#Cc1nc(F)cnc1O

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 2/20 0.31
FEN1 P39748 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27794034 0.83 ALOX5AP (0.33) ALOX5APFEN1
SCHEMBL29093198 0.83 ALOX5AP (0.32) ALOX5APFEN1
SCHEMBL28456157 0.82 CTSK (0.39) ALOX5APFEN1
SCHEMBL29379576 0.78 CYP11B2 (0.33)
SCHEMBL1338236 0.78 CYP11B2 (0.33)
SCHEMBL23508934 0.75 HTT (0.33)
SCHEMBL6376942 0.75 ALDH1A1 (0.36)
SCHEMBL15257937 0.75 JAK3 (0.33)
SCHEMBL28464487 0.75 TTR (0.30)
SCHEMBL6375598 0.75 ALOX5AP (0.42) ALOX5APFEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230098076-A1 A PROCESS FOR PREPARATION OF 3,6-DICHLOROCYANO PYRAZINE, 3,6-DIOXOPIPERAZINE DERIVATIVES AND PRODUCTION OF FAVIPIRAVIR THEREOF COUNCIL OF SCIENT AND INDUSTRIAL RESEARCH AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN (IN) 2023-03-30 US claimed
CN-113106130-B Application of nitrile hydratase derived from staphylococcus aggregatus in preparation of amide pyrazine compounds 核芯生物医药科技(杭州)有限公司 2023-03-14 CN claimed
CN-113025671-B Application of nitrile hydratase derived from sinorhizobium meliloti in preparation of amide pyrazine compounds 浙江恒康药业股份有限公司 2023-01-31 CN claimed
CN-112552245-B Synthesis method of Favipiravir 苏州正济药业有限公司 2022-08-02 CN claimed
WO-2022009036-A1 SYNTHESIS OF FAVIPIRAVIR OPTIMUS DRUGS (P) LTD (IN) 2022-01-13 WO claimed
CN-215277128-U Automatic feeding device for synthesizing 6-fluoro-3-hydroxy-2-cyanopyrazine 江西美晶科技有限公司 2021-12-24 CN claimed
CN-215196902-U Efficient hydrolysis reaction kettle for 6-fluoro-3-hydroxy-2-cyanopyrazine 江西美晶科技有限公司 2021-12-17 CN claimed
WO-2021250705-A1 A PROCESS FOR PREPARATION OF 3,6-DICHLOROCYANO PYRAZINE, 3,6-DIOXOPIPERAZINE DERIVATIVES AND PRODUCTION OF FAVIPIRAVIR THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860)) (IN) 2021-12-16 WO claimed
WO-2021240295-A1 PROCESS FOR PREPARATION OF FAVIPIRAVIR GLENMARK LIFE SCIENCES LIMITED (IN) 2021-12-02 WO claimed
CN-113252800-A HPLC (high performance liquid chromatography) detection method for Pilarvir and related substances thereof and application of method 北京四环制药有限公司 2021-08-13 CN claimed
CN-113025671-A Application of nitrile hydratase derived from sinorhizobium meliloti in preparation of amide pyrazine compounds 浙江恒康药业股份有限公司 2021-06-25 CN claimed
CN-111662938-B Application of nitrile hydratase in catalyzing hydration reaction of cyanopyrazine compound to generate amide pyrazine compound 浙江恒康药业股份有限公司 2021-05-04 CN claimed
CN-112645889-A Refining method of Favipiravir 杭州煌森生物科技有限公司 2021-04-13 CN claimed
CN-112552245-A Synthesis method of Favipiravir 苏州正济药业有限公司 2021-03-26 CN claimed
CN-111675663-A Preparation method of Favipiravir 杭州煌森生物科技有限公司 2020-09-18 CN claimed
CN-111662938-A Application of nitrile hydratase in catalyzing hydration reaction of cyanopyrazine compound to generate amide pyrazine compound 浙江恒康药业股份有限公司 2020-09-15 CN claimed
EP-2192117-B1 ORGANIC AMINE SALT OF 6-FLUORO-3-HYDROXY-2-PYRAZINECARBONITRILE AND METHOD FOR PRODUCING THE SAME TOYAMA CHEMICAL CO LTD (JP) 2014-06-04 EP claimed
US-8168789-B2 Organic amine salt of 6-fluoro-3-hydroxy-2-pyrazinecarbonitrile and method for producing the same TOYAMA CHEMICAL CO., LTD. (JP) 2012-05-01 US claimed
US-20100286394-A1 ORGANIC AMINE SALT OF 6-FLUORO-3-HYDROXY-2-PYRAZINECARBONITRILE AND METHOD FOR PRODUCING THE SAME TOYAMA CHEMICAL CO., LTD. (JP) 2010-11-11 US claimed
EP-2192117-A1 ORGANIC AMINE SALT OF 6-FLUORO-3-HYDROXY-2-PYRAZINECARBONITRILE AND METHOD FOR PRODUCING THE SAME Toyama Chemical Co., Ltd. (JP) 2010-06-02 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230098076-A1 A PROCESS FOR PREPARATION OF 3,6-DICHLOROCYANO PYRAZINE, 3,6-DIOXOPIPERAZINE DERIVATIVES AND PRODUCTION OF FAVIPIRAVIR THEREOF CBR3, CYP4F3, CYP3A5 ALOX5AP 615/4885FEN1 2774/4885
US-20100286394-A1 ORGANIC AMINE SALT OF 6-FLUORO-3-HYDROXY-2-PYRAZINECARBONITRILE AND METHOD FOR PRODUCING THE SAME AOC2, HTR2A, HTR2C ALOX5AP 1710/4885FEN1 3759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.